Relevant bibliographies by topics / Hu 4796

Contents

  1. Journal articles
  2. Books

Academic literature on the topic 'Hu 4796'

Author: Grafiati
Published: 27 July 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hu 4796.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hu 4796"

1

Yang, Lian-Fang, Ben-Jin Hu, and John C. Morse. "Interesting new Chinese species of Leptoceridae and Odontoceridae (Insecta Trichoptera) from several recent collecting efforts." Zootaxa 4766, no. 4 (2020): 593. https://doi.org/10.11646/zootaxa.4766.4.6.

Full text
Abstract:
Yang, Lian-Fang, Hu, Ben-Jin, Morse, John C. (2020): Interesting new Chinese species of Leptoceridae and Odontoceridae (Insecta Trichoptera) from several recent collecting efforts. Zootaxa 4766 (4): 593-593, DOI: 10.11646/zootaxa.4766.4.6
APA, Harvard, Vancouver, ISO, and other styles
2

Alshoabi, Sultan Abdulwadoud, Reyan Mohammed Alharbi, Rufaydah Bader Algohani, et al. "Grading of Fatty Liver Based on Computed Tomography Hounsfield Unit Values versus Ultrasonography Grading." Gastroenterology Insights 15, no. 3 (2024): 588–98. http://dx.doi.org/10.3390/gastroent15030043.

Full text
Abstract:
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) ranges from hepatic steatosis to nonalcoholic steatohepatitis and may lead to liver cirrhosis. This study aimed to assess the feasibility of numerical grading MASLD using noncontrast computed tomography (NCCT). Methods: In a retrospective study of 166 patients diagnosed with MASLD between June 2020 and January 2024, MASLD was graded by ultrasonography, and liver density was measured on NCCT. The MASLD grades and NCCT densities were compared. Results: The MASLD grades were distributed as follows: grade 0 (n = 79, 47.6%
APA, Harvard, Vancouver, ISO, and other styles
3

Hamouda, Abdelrahman M., Zach Pennington, Rahul Kumar, et al. "Impact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications." Journal of Clinical Medicine 14, no. 9 (2025): 3247. https://doi.org/10.3390/jcm14093247.

Full text
Abstract:
Introduction: Bone health optimization is a key component of the preoperative management of spine surgery patients, as poor bone quality increases the odds of mechanical complications. The present study aimed to achieve the following: (1) compare the relative efficacy of current osteoporosis medications in improving bone quality; (2) identify factors influencing treatment response in preoperative spine surgery patients. Methods: Patients treated at a single, multisite institution who received osteoporosis treatment were identified. Data were gathered on pre- and post-treatment lumbar spine Hou
APA, Harvard, Vancouver, ISO, and other styles
4

Linh, Đỗ Đức, Đoàn Thị Giang, Đinh Trung Thành та Phạm Hồng Đức. "Đánh giá mối tương quan giữa lắng đọng mỡ tuyến tụy trên cắt lớp vi tính với chỉ số khối cơ thể và đái tháo đường tuýp 2". Tạp chí Nghiên cứu Y học 180, № 7 (2024): 213–22. http://dx.doi.org/10.52852/tcncyh.v180i7.2553.

Full text
Abstract:
Nghiên cứu nhằm mục đích xác định các mức độ lắng đọng mỡ trong tụy (IPFD) trên cắt lớp vi tính ở người bình thường và đánh giá mối tương quan với các chỉ số khối cơ thể (BMI) và đái tháo đường tuýp 2. Các chỉ số này nhằm xác định IPFD qua quan sát (chia làm 4 độ 0, 1, 2, 3) và đo tỷ trọng xác định trên cắt lớp vi tính. Tổng có 208 người độ tuổi 47,6 ± 14,8 được chụp cắt lớp vi tính ổ bụng và xác định là không có bệnh lý viêm hoặc u tụy. Kết quả cho thấy: độ 0, 1, 2 chiếm tỷ lệ ở vùng đầu tụy và đuôi tụy lần lượt là: 86,5%, 12% và 1,4%; và 86,1%, 13%, và 1,0%, không có trường hợp nào lắng đọng
APA, Harvard, Vancouver, ISO, and other styles
5

Alvarez, Ofelia A., Sandra Echenique, Hector Rodriguez-Cortes, et al. "Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement." Blood 134, Supplement_1 (2019): 5862. http://dx.doi.org/10.1182/blood-2019-123215.

Full text
Abstract:
The Health Resources and Services (HRSA)-sponsored Sickle Cell Disease (SCD)Treatment Demonstration Regional Collaborative Program, EMBRACE SCD Florida has three aims: 1. To educate providers about SCD, 2. To assess patients' perception on health care and barriers encountered, and 3. To increase hydroxyurea (HU) treatment as disease-modifying therapy. We report the patients' perception on health care delivery as assessed by surveys of 65 patients at two SCD centers in South Florida. All participants signed the IRB-approved informed consent/assent and completed a 46-question survey. Surveys add
APA, Harvard, Vancouver, ISO, and other styles
6

Ballout, Farah, Heng Lu, Zheng Chen, et al. "Abstract 4776: NRF2 is overexpressed in esophageal adenocarcinoma and its targeting sensitizes tumor cells to cisplatin through induction of ferroptosis and apoptosis." Cancer Research 83, no. 7_Supplement (2023): 4776. http://dx.doi.org/10.1158/1538-7445.am2023-4776.

Full text
Abstract:
Abstract Background: Esophageal adenocarcinoma (EAC) is the predominant type of esophageal cancer in the United States, with the 5-year survival rate is below 20%. EAC develops through Barrett’s esophagus (BE)-dysplasia-carcinoma cascade. Gastroesophageal reflux disease (GERD), where acidic bile salts refluxate into the esophagus, is the main risk factor for the development of BE and its progression to EAC. The NFE2-related factor 2 (NRF2) is the master cellular antioxidant regulator, involving in many cancer hallmarks. Methods and Results: Using western blotting and immunohistochemistry techn
APA, Harvard, Vancouver, ISO, and other styles
7

Zhu, Kuichun, Elvira Gerbino, Darrin M. Beaupre, et al. "Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells." Blood 105, no. 12 (2005): 4759–66. http://dx.doi.org/10.1182/blood-2004-11-4307.

Full text
Abstract:
Abstract Despite major advances, multiple myeloma (MM) remains an incurable malignancy. Recently we have found that disease stabilization was achieved in 64% of patients with advanced MM treated with the farnesyltransferase inhibitor R115777 (Zarnestra) in a phase 2 clinical trial. In order to enhance R115777 antitumor activity in MM, we examined the combination of this novel agent with other anticancer drugs in MM cell lines. In this study, R115777 was found to synergize with paclitaxel and docetaxel, but not with other chemotherapy agents, including doxorubicin, 5-fluorouracil, cisplastin, m
APA, Harvard, Vancouver, ISO, and other styles
8

Alhejazi, Ayman, Mahmoud Aljurf, Entezam Sahovic, et al. "Leukemia during Pregnancy: 32 Cases from a Single Institution." Blood 104, no. 11 (2004): 3153. http://dx.doi.org/10.1182/blood.v104.11.3153.3153.

Full text
Abstract:
Abstract In an attempt to evaluate the outcome of leukemia during pregnancy we performed a study of all such cases identified in our institution leukemia database. Thirty two cases were identified as cases of leukemia during pregnancy among the cohort of patients treated between January 1991 and July 2003. The cases were AML (15), ALL (6) and CML (11). At diagnosis the median age was 24.5 years and the median gestational age was 16 weeks. Twenty patients were treated for their leukemia during pregnancy at a median gestational age of 20 weeks (4 in the first trimester, 8 in the second trimester
APA, Harvard, Vancouver, ISO, and other styles
9

Fauny, M., M. Halin, E. Allado, et al. "AB1334 SCANOGRAPHIC EVALUATION OF BONE FRAGILITY 2 YEARS AFTER BARIATRIC SURGERY IN OBESE PATIENTS: AN OBSERVATIONAL STUDY." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 1773.2–1773. http://dx.doi.org/10.1136/annrheumdis-2022-eular.871.

Full text
Abstract:
BackgroundOsteoporosis is a common disease whose prognosis can be seriously impacted by the development of fractures that lead to functional limitations and may even have life-threatening sequelae (1). CT is useful for diagnosing vertebral fracture (VF) and measuring the scanographic bone attenuation coefficient of the first lumbar vertebra (SBAC- L1). Obesity might be a protective factor against bone loss and osteoporosis (2). Nonetheless, epidemiological studies have reported an association between obesity and an increased risk of fragility fractures (3) and suggested that obesity may be a r
APA, Harvard, Vancouver, ISO, and other styles
10

Jain, Akshat, Lisa Roberts, and Safiye Sahin. "Global Sickle Cell Quality of Life: Oral Pain Medication Frequency, Health Outcomes, and Emotional Well-Being." Blood 144, Supplement 1 (2024): 5060. https://doi.org/10.1182/blood-2024-206337.

Full text
Abstract:
Background: Sickle cell disease (SCD) profoundly affects physical health, emotional well-being, and overall quality of life(QOL). Oral pain medication (OPM) use is essential to manage vaso occlusion in SCD and is a key utilization metric for disease severity and management effectiveness. Understanding how this frequency relates with health status, treatment practices, and psychosocial factors may explain unmet needs in these regions and help direct public policy. We investigated the relationships between frequency of OPM usage and key physical, psychosocial health metrics, and satisfaction wit
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hu 4796"

1

Pynchon, Thomas. V. Perennial Library, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pynchon, Thomas. V. Harper & Row, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pynchon, Thomas. V. "Simpozium", 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pynchon, Thomas. V. Harper Perennial Modern Classics, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pynchon, Thomas. V.: A Novel. HarperCollins Publishers, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pynchon, Thomas. V. Harper Perennial Modern Classics, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pynchon, Thomas. V. Tusquets, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pynchon, Thomas. V. Seuil, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pynchon, Thomas. V. Tandem Library, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hu 4796' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography